MedTrace Logo

Effectiveness and Cost-Effectiveness of Four Formulations of Food Supplements for the Prevention of Wasting and Stunting in Burkina Faso

NCT02071563 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6039

Last updated 2017-10-24

No results posted yet for this study

Summary

This research will serve as a follow-up on the review of Title II commodities performed by the Food Aid Quality Review at Tufts University in October 2011. The study in Burkina Faso will test the relative effectiveness and cost effectiveness of four supplementary foods in the prevention of MAM and stunting in normal programmatic settings.

The aims of this study are to:

1. To compare the effectiveness of four alternative supplementary food commodities in preventing stunting and wasting, and promoting linear growth in children 6 - 23 months in the context of a preventive supplementary feeding program in Burkina Faso.
2. To estimate the relative cost of implementing the supplementary feeding program using each commodity
3. To estimate the relative cost/effectiveness of implementing the program using each commodity.

Conditions

  • Child Malnutrition

Interventions

DIETARY_SUPPLEMENT

CSB14

DIETARY_SUPPLEMENT

RUSF1

DIETARY_SUPPLEMENT

SC+

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • ACDI/VOCA

    collaborator OTHER

  • Save the Children

    collaborator OTHER

  • Institut de Recherche en Sciences de la Sante, Burkina Faso

    collaborator OTHER_GOV

  • Tufts University

    lead OTHER

Principal Investigators

  • Beatrice L Rogers, PhD · Tufts University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
23 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2017-01-31
Completion
2017-06-30

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02071563 on ClinicalTrials.gov